Skip to content
    Guidelines & Consensus

    US Multi-Society Task Force Consensus Statement

    Rex et alGastroenterology

    Serrated polyposis syndrome (SPS) represents the most prevalent polyposis syndrome, yet it frequently remains underrecognized in clinical practice. The US Multi-Society Task Force on Colorectal Cancer has issued a consensus statement outlining diagnostic, surveillance, and risk-management strategies for the condition. Diagnosis continues to rely strictly on established World Health Organization clinical criteria, which account for the cumulative lifetime count, dimensions, and anatomical distribution of serrated polyps across the colon.
    Patients with SPS face an elevated risk for both prevalent and incident colorectal cancer (CRC). To mitigate incident malignancy, the consensus statement recommends meticulous endoscopic mucosal inspection, complete endoscopic clearing of polyps, and frequent colonoscopic surveillance. Colorectal surgical intervention is reserved for patients diagnosed with invasive CRC or those exhibiting an extensive polyp burden that cannot be safely or completely controlled by expert endoscopists.
    Because SPS is not linked to a single common germline pathogenic variant, broad germline genetic testing is not routinely advised. Genetic evaluation should be pursued only when clinical features suggest another specific, established hereditary cancer syndrome. In addition, first-degree relatives of individuals with SPS harbor an elevated risk of CRC and should be directed to undergo screening colonoscopy.

    Key Takeaways

    • The US Multi-Society Task Force recommends meticulous mucosal inspection, complete clearing of the colon, and frequent surveillance colonoscopy to reduce incident colorectal cancer, reserving surgical resection for invasive malignancy or polyp burdens unmanageable endoscopically.
    • Routine germline genetic testing is not indicated for serrated polyposis syndrome because no common pathogenic variant exists; testing should be restricted to individuals meeting criteria for other known hereditary syndromes in appropriate clinical settings.
    • First-degree relatives of individuals diagnosed with serrated polyposis syndrome face an elevated risk of colorectal cancer and should undergo screening colonoscopy.
    Read the original sourceGastroenterology